09:29 AM EST - Appili Therapeutics Inc. : Announced its financial and operational results for the fiscal year ended March 31, 2022. The net loss and comprehensive loss of $25.1 million or $0.38 loss per share was $10.8 million higher than the net loss and comprehensive loss of $14.3 million or $0.24 loss per share during the year ended March 31, 2021. Appili Therapeutics Inc.
shares T.APLI are trading unchanged at $0.07.
